Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Rifabutin Pfizer Brand

Client Email

Product

Rifabutin Pfizer Brand
US Patents

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Rifabutin Pfizer Brand

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

7 API Suppliers, 3 USDMF, 1 CEP/COS, 2 EU WC, 1 NDC API, 4 Listed Suppliers, $ API Reference Price

7 API Suppliers
3 USDMF
1 CEP/COS
2 EU WC
1 NDC API
4 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

INTERMEDIATES

1 API Suppliers

1 API Suppliers

FINISHED DOSAGE FORMULATIONS

13 FDF Dossiers, 4 FDA Orange Book, 4 Europe, 1 Canada, 2 Australia, 1 South Africa, 1 Listed Dossiers

13 FDF Dossiers
4 FDA Orange Book
4 Europe
1 Canada
2 Australia
1 South Africa
1 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 7 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 4 ACG Worldwide, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 2 DFE Pharma, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Kerry, 3 Lonza Capsugel, 8 Microlex e.U, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 9 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

1 SPI Pharma
7 DKSH
4 Boai NKY Pharmaceuticals Ltd
6 Gangwal Healthcare
4 ACG Worldwide
1 Alcedo Pharmachem
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
11 BASF
2 DFE Pharma
7 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
4 Kerry
3 Lonza Capsugel
8 Microlex e.U
1 Novo Excipients
2 Pharmatrans-Sanaq
2 Pluviaendo
2 Prachin Chemical
1 Qualicaps
9 Roquette
1 Seppic
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
8 Sigachi Industries
1 Ulanqab Kema New Material
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

27 Fillers, Diluents & Binders, 21 Direct Compression, 18 Thickeners and Stabilizers, 16 Disintegrants & Superdisintegrants, 13 Granulation, 13 Lubricants & Glidants, 11 Coating Systems & Additives, 9 Co-Processed Excipients, 8 Empty Capsules, 5 Taste Masking, 5 Controlled & Modified Release, 5 Chewable & Orodispersible Aids, 4 Film Formers & Plasticizers, 3 Solubilizers, 3 Emulsifying Agents, 2 Coloring Agents, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Topical, 1 Rheology Modifiers

27 Fillers, Diluents & Binders
21 Direct Compression
18 Thickeners and Stabilizers
16 Disintegrants & Superdisintegrants
13 Granulation
13 Lubricants & Glidants
11 Coating Systems & Additives
9 Co-Processed Excipients
8 Empty Capsules
5 Taste Masking
5 Controlled & Modified Release
5 Chewable & Orodispersible Aids
4 Film Formers & Plasticizers
3 Solubilizers
3 Emulsifying Agents
2 Coloring Agents
1 API Stability Enhancers
1 Surfactant & Foaming Agents
1 Topical
1 Rheology Modifiers

DIGITAL CONTENT

9 NEWS #PharmaBuzz

9 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 3 Finished Drug Prices

2 US Medicaid Prescriptions
3 Finished Drug Prices

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

7 US Patents, 2 US Exclusivities

7 US Patents
2 US Exclusivities

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 2 Others

2 EDQM
1 USP
2 Others

$ API Ref.Price (USD/KG) : 3,553 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

7 All

01 7REDHILL

filter Patent Number Reset all filters

7 All

01 19050263

02 19498445

03 19603806

04 110238606

05 111135172

06 111878011

07 111931463

filter API Patent Reset all filters

7 All

01 7Blank

filter FDF Patent Reset all filters

7 All

01 6Y

02 1Blank

filter Expiration Date Reset all filters

7 All

01 62034-02-12

02 12042-05-27

US Patents
US Exclusivities

Product Main Page

01

REDHILL

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Formnext Forum

Not Confirmed

REDHILL

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-02-12

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

US Patent Number : 9603806

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213004

Patent Use Code : U-2660

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

REDHILL

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Formnext Forum

Not Confirmed

REDHILL

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-02-12

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

US Patent Number : 9498445

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213004

Patent Use Code : U-2660

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

REDHILL

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Formnext Forum

Not Confirmed

REDHILL

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-02-12

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

US Patent Number : 9050263

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213004

Patent Use Code : U-2660

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

REDHILL

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Formnext Forum

Not Confirmed

REDHILL

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2042-05-27

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

US Patent Number : 11878011

Drug Substance Claim :

Drug Product Claim :

Application Number : 213004

Patent Use Code : U-3816

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-05-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

REDHILL

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Formnext Forum

Not Confirmed

REDHILL

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-02-12

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

US Patent Number : 11135172

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213004

Patent Use Code : U-2660

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

REDHILL

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Formnext Forum

Not Confirmed

REDHILL

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-02-12

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

US Patent Number : 11931463

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213004

Patent Use Code : U-3866

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

REDHILL

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Formnext Forum

Not Confirmed

REDHILL

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-02-12

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

US Patent Number : 10238606

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213004

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?